|
|
|
Volumn 52, Issue 3, 2011, Pages 72-75
|
|
Treatment of bacterial vaginosis does not reduce preterm birth among high-risk asymptomatic women in fetal fibronectin positive patients.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
FETOPROTEIN;
FIBRONECTIN;
METRONIDAZOLE;
ADULT;
APGAR SCORE;
ARTICLE;
BIRTH WEIGHT;
CHI SQUARE DISTRIBUTION;
COMPARATIVE STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GESTATIONAL AGE;
HUMAN;
MATERNAL AGE;
NEWBORN;
NONPARAMETRIC TEST;
PARITY;
PH;
PREGNANCY;
PREGNANCY COMPLICATION;
PREGNANCY OUTCOME;
PREMATURITY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TIME;
VAGINITIS;
ADULT;
ANTI-INFECTIVE AGENTS;
APGAR SCORE;
BIRTH WEIGHT;
CHI-SQUARE DISTRIBUTION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FETAL PROTEINS;
FIBRONECTINS;
GESTATIONAL AGE;
HUMANS;
HYDROGEN-ION CONCENTRATION;
INFANT, NEWBORN;
MATERNAL AGE;
METRONIDAZOLE;
PARITY;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
PREMATURE BIRTH;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
STATISTICS, NONPARAMETRIC;
TIME FACTORS;
VAGINOSIS, BACTERIAL;
|
|
EID: 79958274171
PISSN: 00266396
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
